11130 Federal Register / Vol. 62, No. 47 / Tuesday, March 11, 1997 / Proposed Rules

had received in a comment to a separate

rulemaking. Because it might consider

the results of these three studies in

developing a final rule in the nutrient

content/health claim proceeding, FDA

also announced that it was reopening

the comment period for that rulemaking

to provide an opportunity for interested

persons to comment on the studies.

FDA has received two requests for an

extension of the comment period. The

requests were from a trade association,

for an extension of 30 days, and from a

consumer group, for an extension of 45

days. The request from the consumer

group indicated a need to seek outside

experts to review and analyze the

studies and, if necessary, to conduct

survey research. The other, from the

trade association whose petition led to

the nutrient content/health claim

proceeding, noted that the author of the

FDA Study had remarked in the study’s

Executive Summary about the

complexity of the study findings and

said that it was ‘‘equally complex for

interested parties to analyze the

research and to comment on the

applicability of the findings to the

proposed rule.’’

After careful consideration, FDA has

decided that some additional time is

necessary for interested persons to

review the results of the FDA Study and

other studies and to submit meaningful

comments on them. Therefore, FDA is

extending the comment period for the

proposal for an additional 45 days, until

April 24, 1997.

Interested persons may, on or before

April 24, 1997, submit to the Dockets

Management Branch (address above)

written comments regarding the studies

that were added to this docket on

January 24, 1997. Two copies of any

comments are to be submitted, except

that individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday.

Dated: March 6, 1997.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 97–6145 Filed 3–7–97; 9:39 am]

BILLING CODE 4160–01–F

ARCHITECTURAL AND

TRANSPORTATION BARRIERS

COMPLIANCE BOARD

36 CFR Parts 1190 and 1191

Accessibility Guidelines for Play

Facilities; Notice of Meeting of

Regulatory Negotiation Committee

AGENCY: Architectural and

Transportation Barriers Compliance

Board.

ACTION: Notice of committee meeting.

SUMMARY: The Architectural and

Transportation Barriers Compliance

Board (Access Board) has established a

regulatory negotiation committee to

develop a proposed rule on accessibility

guidelines for newly constructed and

altered play facilities covered by the

Americans with Disabilities Act and the

Architectural Barriers Act. This

document announces the dates, times,

and location of the next meeting of the

committee, which is open to the public.

DATES: The committee will meet on:

Wednesday, April 2, 1997, 8:30 a.m. to

5:00 p.m.; Thursday, April 3, 1997, 8:30

a.m. to 5:00 p.m.; Friday, April 4, 1997,

8:30 a.m. to 3:00 p.m.

ADDRESSES: The committee will meet at

the Consumer Product Safety

Commission, 4330 East-West Highway

(North Tower), Bethesda, Maryland.

FOR FURTHER INFORMATION CONTACT:

Peggy Greenwell, Office of Technical

and Information Services, Architectural

and Transportation Barriers Compliance

Board, 1331 F Street, NW., suite 1000,

Washington, DC, 20004–1111.

Telephone number (202) 272–5434

extension 34 (Voice); (202) 272–5449

(TTY). This document is available in

alternate formats (cassette tape, braille,

large print, or computer disc) upon

request.

SUPPLEMENTARY INFORMATION: In

February 1996, the Access Board

established a regulatory negotiation

committee to develop a proposed rule

on accessibility guidelines for newly

constructed and altered play facilities

covered by the Americans with

Disabilities Act and the Architectural

Barriers Act. (61 FR 5723, February 14,

1996.) The committee will hold its next

meeting on the dates and at the location

announced above. The meeting is open

to the public. The meeting site is

accessible to individuals with

disabilities. Individuals with hearing

impairments who require sign language

interpreters should contact Peggy

Greenwell by March 24, 1997, by calling

(202) 272–5434 extension 34 (voice) or

(202) 272–5449 (TTY).

Lawrence W. Roffee,

Executive Director.

[FR Doc. 97–6028 Filed 3–10–97; 8:45 am]

BILLING CODE 8150–01–P

ENVIRONMENTAL PROTECTION

AGENCY

40 CFR Chapter I

[OPP–00473; FRL–5594–6]

Antimicrobial Rule Development and

Establishment of Docket; Stakeholder

Meeting

AGENCY: Environmental Protection

Agency (EPA).

ACTION: Notice of Public Meeting.

SUMMARY: The Antimicrobials Division

(AD) of the Office of Pesticide Programs

of EPA is holding a series of stakeholder

meetings to obtain views about the

antimicrobial rule that is being

developed. The rule is being revised in

accordance with principles set forth in

the Food Quality Protection Act. To

ensure that all interested parties can

obtain information about activities

related to developing this rule, AD is

voluntarily opening a docket that will

include, but will not be limited to, a

summary of major discussions at

stakeholder meetings, as well as copies

of any documents distributed at these

meetings.

DATE: The next stakeholder meetings

will take place on Wednesday, March 12

from 10:30 a.m. to 12:30 p.m.; Thursday,

April 3 from 2 p.m. to 5 p.m.; Thursday,

May 8 from 2 p.m. to 5 p.m.; Tuesday,

June 3 from 10 a.m. to 12 noon.

ADDRESSES: The March 12, 1997

meeting will be held in Rm. 1126,

Crystal Mall #2, 1921 Jefferson Davis

Highway, Arlington, VA. To find out the

locations of the other three meetings,

please call the contact person listed

below.

FOR FURTHER INFORMATION CONTACT: By

mail: Barbara Mandula, Antimicrobials

Division (7505W), U.S. Environmental

Protection Agency, 401 M St., SW.,

Washington, DC 20460; Office location,

telephone, and e-mail address: Sixth

Floor, Crystal Station #1, 2800 Crystal

Drive, Arlington, VA 22202, 703–308–

7378; fax: 703–308–6467; e-mail:

mandula.barbara@epamail.epa.gov.

SUPPLEMENTARY INFORMATION: This

notice announces a series of public

meetings to ensure that all parties

interested in the development of

antimicrobial rules can obtain